Midazolam and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Midazolam (midazolam) and Pulmicort (budesonide). Common drug interactions include drug ineffective among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Midazolam and Pulmicort. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.



On Jul, 26, 2026

56 people who take Midazolam and Pulmicort together, and have interactions are studied.

Midazolam and Pulmicort drug interactions.

What are the common drug interactions of Midazolam and Pulmicort, by gender? *:

female:

  1. Drug ineffective
  2. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
  3. Dyspepsia (indigestion)
  4. Nausea (feeling of having an urge to vomit)
  5. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
  6. Pyrexia (fever)
  7. Anaemia (lack of blood)
  8. Abdominal pain
  9. Colitis (inflammation of colon)
  10. Colitis ulcerative (inflammation of colon with ulcer)

male:

  1. Pneumonia
  2. Atelectasis (partial or complete collapse of the lung)
  3. Influenza
  4. Lower respiratory tract infection
  5. Platelet count decreased
  6. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  7. Intestinal obstruction
  8. Post procedural pneumonia
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Full blood count increased

What are the common drug interactions of Midazolam and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Blood pressure decreased
  3. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  4. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  5. Pneumonia
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Death
  8. Lower respiratory tract infection

20-29:

  1. Haematocrit
  2. Haemoglobin decreased
  3. Influenza
  4. Platelet count decreased
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Full blood count increased
  8. Sinusitis (inflammation of sinus)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Drug ineffective
  2. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
  3. Constipation
  4. Erythema (redness of the skin)
  5. Female genital tract fistula (passage in genital tract of female)
  6. Frequent bowel movements
  7. Haematochezia (passage of stools containing blood)
  8. Headache (pain in head)
  9. Rectal haemorrhage (bleeding from anus)
  10. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 40 people, 71.43%
  2. Allergies: 25 people, 44.64%
  3. Colitis (inflammation of colon): 21 people, 37.50%
  4. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 11 people, 19.64%
  5. Fever: 11 people, 19.64%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 17.86%
  7. Nausea (feeling of having an urge to vomit): 7 people, 12.50%
  8. Urethral Disorder: 4 people, 7.14%
  9. Sedation: 4 people, 7.14%
  10. Spinal Muscular Atrophy (wasting of spinal muscles): 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Midazolam and Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Midazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pulmicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on midazolam and budesonide (the active ingredients of Midazolam and Pulmicort, respectively), and Midazolam and Pulmicort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: